Page 205 - Vitamin D and Cancer

192 F.S.G. Cheung and J.K.V. Reichardt

BCC Basal cell carcinoma
2+
Ca Calcium
CaR Calcium receptor
cAMP Cyclic AMP
CBP CREB binding protein
CPDs Cyclobutane pyrimidine dimmers
DAG Diacylglycerol
7-DHC 7-Dehydrocholesterol
DRIP Vitamin D receptor-interacting protein
ERK Extracellular signal-regulated kinase
HATs Histone acetyltransferases
HDACs Histone deacetylases
IP Inositol 1,4,5-triphosphate
3
JNK c-Jun NH2-terminal kinase
MAPK Mitogen-activated protein kinase
MARRS Membrane associated rapid response steroid-binding
MEK MAPK/ERK kinase
MM Malignant melanoma
NCoA62-SKIP Nuclear co-activator 62 kDa-SKI-interacting protein
NCoR Nuclear receptor co-repressor
nVDRE Negative vitamin D response element
NO Nitric oxide
1a-OHase 1a-Hydroxylase
24-OHase 24-Hydroxylase
25-OHase 25-Hydroxylases
25OHD 25-HydroxyvitaminD
3 3
1,25(OH) D 1,25Dihydroxyvitamin D
2 3 3
OPG Osteoprotegrin
PI3K Phosphatidylinositide 3-kinase
PIP Phosphatidylinositol 4,5-bisphosphate
2
PKA Protein kinase A
PKC Protein kinase C
PLC Phospholipase C
PTH Parathyroid hormone
Pol Polymerase
RANKL Receptor activator of NF-kB ligand
RXR Retinoid X receptor
SCC Squamous cell carcinomas
SMRT Silencing mediator for retinoid and thyroid hormone receptors
SRC Steroid receptor co-activators
TD Thymine dimmers
TF2B Transcription factor 2B
TRPV Transient receptor potential vanilliod
UVA Ultraviolet A
UVB Ultraviolet B